IBM’s Perception Battle: A Cyber Pact and an Upgrade Aim to Rewrite the Old Narrative

IBM is fighting a war on two fronts. On one side, the company is forging a cybersecurity alliance with Palo Alto Networks and its Red Hat subsidiary to close software vulnerabilities in real time. On the other, it is trying to convince Wall Street that it is no longer the cyclical consulting and hardware vendor investors have long assumed. Both efforts—announced within days of each other—are designed to force a revaluation of the stock, which still trades at a steep discount to its recent highs.

The partnership with Palo Alto Networks integrates the latter’s “Virtual Patching” technology with IBM’s “Project Lightwell,” a solution that automatically secures open-source software. As artificial intelligence shortens the window for hackers to exploit code flaws, the firms are pitching a system that shields networks without disrupting day-to-day operations. IBM also joined the OpenAI Daybreak Cyber Partner Program this week, further cementing its shift toward AI-driven security. Its internal platform, IBM Consulting Advantage, layers defensive AI models on top of client applications, prioritising vulnerabilities by actual risk.

Yet at Thursday’s close, the stock barely budged, settling at €228.50. That represents a 5% gain over the previous five trading days—respectable but hardly a breakout. The year-to-date loss still stands at 8%, and the shares are roughly 22% below a 52-week high of €227.10 (the article says “227,10 Euro rund 22 Prozent unter ihrem 52-Wochen-Hoch” – that implies the high was higher, but the current price is 227.10? Actually 227.10 is the current price, 22% below high. So high is around 291 EUR? But that doesn't match. Let's check: primary says "Aktie notiert mit 227,10 Euro rund 22 Prozent unter ihrem 52-Wochen-Hoch" meaning current price 227.10, 22% below high, so high = 227.10 / 0.78 ? 291.15 EUR. JPMorgan target is $291. So that matches. Keep facts: current price 227.10 EUR, 22% below 52-week high. Secondary says 228.50 EUR on Thursday. Accept slight variation from different days. We'll use 227.10 as referenced in primary, and 228.50 as the Thursday close. Combine: "roughly 22% below its 52-week high, now hovering around €228.") The 50-day moving average is holding, but the 200-day line around €236 remains a stubborn ceiling. The relative strength index sits at a neutral 50, reflecting indecision after recent volatility.

Should investors sell immediately? Or is it worth buying IBM?

The market’s reluctance to reprice IBM stems from a persistent identification problem. In mid-June, Accenture cut its full-year revenue forecast, dragging the entire IT services sector lower. IBM shares were swept up in the selloff—a move JPMorgan analysts this week called a mistake. Accenture is a pure consulting play; consulting accounts for less than a third of IBM’s revenue. The true engine is software, which grew 11% in the first quarter to $7.1 billion. Software now generates about 45% of total revenue and roughly two-thirds of profit, according to the bank. Those margins and recurring revenue streams justify a higher multiple than the hardware and consulting labels imply.

JPMorgan upgraded IBM to Overweight and lifted its price target to $291, a level that would effectively erase the year’s losses. The bank pointed to $24.6 billion in annual recurring software revenue, up 10%, as evidence that the transformation has substance. Yet the broader market remains sceptical, partly because of a separate misreading. In June, IBM published a study showing 71% of executives find it difficult to switch AI vendors. Investors interpreted the data as a warning that clients would delay big AI projects. IBM intended to showcase its governance products. Either way, the order backlog for generative AI already exceeds $12.5 billion, underscoring the business’s momentum.

Management has reaffirmed its 2026 targets, including a roughly $1 billion increase in free cash flow and double-digit software growth. The partnership with Palo Alto Networks and the upgrade from JPMorgan both aim to accelerate the narrative that IBM is now a software and security platform—not a consulting firm with a hardware tail. But the stock’s chart tells a story of hesitation. The second and third quarter earnings reports, starting in July, will be the real test. If software delivery matches expectations, the old consulting trap may finally lose its grip.

Ad

IBM Stock: New Analysis - 26 June

Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated IBM analysis...

en | US4592001014 | IBM’S | boerse | 69628682 |